Chinese Adults With Kidney Disease

Clinical trial NCT07522099 · RECRUITING

Trial details

NCT number: NCT07522099
Sponsor: ADARx Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Immunoglobulin A Nephropathy (IgAN)Complement 3 Glomerulopathy (C3G)IC-MPGN

Start date: 2026-05-21
Primary completion: 2028-07-10
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.